Chris D'Angelo

Christopher D’Angelo, MDChristopher D'Angelo MD
Assistant Professor, Internal Medicine
Division of Oncology & Hematology

Academic office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax 402-559-6520

Practice locations:
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

Education:
Northwestern University, Evanston, IL, (2008)
University of Illinois, College of Medicine, Chicago, IL, (2013)
University of Chicago, Internal medicine Residency, Chicago, IL (2016)
University of Wisconsin, Hematology/Oncology Fellowship, Madison, IL (2019)

University of Wisconsin, Fundamentals of Clinical Research post-graduate certificate Program, Madison, WI (2020)

 

Hospital Appointments:
Nebraska Medicine

Interests:
Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Early Phase Clinical Trials

Biographical Sketch:
Dr. Christopher D’Angelo is an Assistant Professor in the Department of Internal Medicine, Division of Hematology/Oncology. He graduated with honors from the University of Illinois, College of Medicine, Chicago, IL. He then went on to do internal medicine residency and Hematology/Oncology fellowship at the University of Chicago, Chicago, IL. Following this, he attended the University of Wisconsin for his post-graduate certificate in Fundamentals of Clinical Research.

He has authored or co-authored numerous articles, book chapters and abstracts. He has also presented his research at several national meetings and was awarded the UNMC Department of Medicine Scientist Development Award 2021. He has also served as an expert reviewer for a number of scientific journals. He is currently involved in clinical research related to microbiome and dietary intake in patients with CLL.  

Selected Publications:

D’Angelo C, Sudakaran S, Callander N. “Clinical Effects and Applications of the Gut Microbiome in Hematologic Malignancies”. Cancer. 2020. DOI: 10.1002/cncr.33400

Shah S; D’Angelo C.R., Kratz J, Yang DT. “Diagnostic Challenges in an Aggressive Case of Peripheralizing Marginal Zone Lymphoma.” Clinical Case Reports. (2020). DOI: 10.1002/ccr3.3395

D’Angelo C.R., Hall A, Woo K. M., Kim K, Longo W, Hematti P, Callander N, Kenkre V P., Mattison R, and M Juckett. “Decitabine Induction with Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies Is Associated with a High Rate of Infectious Complications.” Leukemia Research. (2020). 96C 106419. doi: 10.1016/j.leukres.2020.106419

Zayac A., Evens A., Danilov A, Smith S, Jagadeesh D, Leslie L, D’Angelo C, Olszewski A. “Outcomes of Burkitt’s Lymphoma with Central Nervous System Involvement: Evidence from a Large Multi-Center Cohort Study.” Haematologica. (2021). DOI: https://doi.org/10.3324/haematol.2020.270876

Evens A. M., Danilov A, Jagadeesh D, Sperling A, Kim S, Vaca R…D’Angelo C…Alderuccio J.P. “Burkitt Lymphoma in the Modern Era: Real-World Outcomes and Prognostication Across 30 US Cancer Centers.”Blood (2020). doi: 10.1182/blood.2020006926

D’Angelo C, Ku K, Gulliver J, Chang J. “Intravascular Large B-Cell Lymphoma Presenting with Altered Mental Status: A Case Report.” World J Clin Oncol. (2019)

Christopher R. D’Angelo., B. Novitsky, S.M. Lee, L. A. Godley, J. Kline, R. A. Larson, H.   Liu, O. Odenike, W. Stock, M. R. Bishop, and A. S. Artz. "Characterization of Cancer Comorbidity Prior to Allogeneic Hematopoietic Cell Transplantation.” Leukemia & Lymphoma (2018)

D'Angelo, C. R., M. Kocherginsky, J. Pisano, M. R. Bishop, L. A. Godley, J. Kline, R. A. Larson, H.   Liu, O. Odenike, W. Stock, and A. S. Artz. "Incidence and Predictors of Respiratory Viral Infections by Multiplex PCR in Allogeneic Hematopoietic Cell Transplant Recipients 50 Years and Older including Geriatric Assessment." Leukemia & Lymphoma (2015)

Schaap-Nutt A, Higgins C, Amaro-Carambot E, Nolan SM, D’Angelo C, Murphy BR, Collins PL, Schmidt AC. (2011) Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of MDA5 and attenuate HPIV-2 replication in nonhuman primates. Journal of Virology. 85, (8) 4007-19

Additional Publications at PubMed.Gov: https://www.ncbi.nlm.nih.gov/pubmed